Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedApr 09, 2026
DataAggregated Company Financials
Companies130
  • 7D1.1%
  • 3M-14.9%
  • 1Y-7.1%
  • YTD-10.2%

Over the last 7 days, the market has risen 1.1%, driven by gains of 1.7% in the Industrials sector. Over the past year the market is down 7.1%. Earnings are forecast to grow by 8.7% annually.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 09 Apr 2026DKK 3.8tDKK 2.0tDKK 237.2b15.4x15.9x1.9x
Sat, 07 Mar 2026DKK 3.8tDKK 2.0tDKK 238.4b16.3x15.8x1.9x
Mon, 02 Feb 2026DKK 4.4tDKK 1.9tDKK 260.8b16.8x17x2.3x
Wed, 31 Dec 2025DKK 4.2tDKK 1.9tDKK 260.5b16.3x16x2.1x
Fri, 28 Nov 2025DKK 4.0tDKK 2.0tDKK 261.9b14.3x15.3x2.1x
Sun, 26 Oct 2025DKK 4.1tDKK 2.0tDKK 287.0b15.3x14.2x2.1x
Tue, 23 Sep 2025DKK 4.1tDKK 1.9tDKK 287.0b15x14.2x2.1x
Thu, 21 Aug 2025DKK 4.0tDKK 1.9tDKK 285.0b15x14.1x2.1x
Sat, 19 Jul 2025DKK 4.3tDKK 1.9tDKK 262.4b15.8x16.4x2.3x
Mon, 16 Jun 2025DKK 4.8tDKK 1.9tDKK 262.6b15.3x18.3x2.6x
Wed, 14 May 2025DKK 4.4tDKK 1.9tDKK 267.2b15.8x16.4x2.3x
Fri, 11 Apr 2025DKK 4.0tDKK 1.9tDKK 259.2b13.3x15.4x2.1x
Sun, 09 Mar 2025DKK 5.2tDKK 1.9tDKK 260.4b14.4x19.9x2.8x
Tue, 04 Feb 2025DKK 5.2tDKK 1.8tDKK 238.7b14.2x21.7x2.8x
Thu, 02 Jan 2025DKK 5.3tDKK 1.8tDKK 238.4b13.8x22x2.9x
Sat, 30 Nov 2024DKK 5.9tDKK 1.8tDKK 237.7b14.2x24.8x3.2x
Mon, 28 Oct 2024DKK 6.0tDKK 1.7tDKK 180.2b15.3x33.3x3.4x
Wed, 25 Sep 2024DKK 6.3tDKK 1.7tDKK 180.0b16x35.1x3.6x
Fri, 23 Aug 2024DKK 6.6tDKK 1.7tDKK 180.5b16.9x36.8x3.8x
Sun, 21 Jul 2024DKK 6.5tDKK 1.7tDKK 186.2b15.3x35.1x3.8x
Tue, 18 Jun 2024DKK 6.9tDKK 1.7tDKK 184.8b15.3x37.2x4x
Thu, 16 May 2024DKK 6.7tDKK 1.7tDKK 184.5b15.5x36.1x3.9x
Sat, 13 Apr 2024DKK 6.4tDKK 1.7tDKK 193.1b15.6x33.1x3.7x
Mon, 11 Mar 2024DKK 6.6tDKK 1.7tDKK 192.0b13.3x34.2x3.8x
Wed, 07 Feb 2024DKK 6.1tDKK 1.8tDKK 225.0b12.9x27.1x3.4x
Fri, 05 Jan 2024DKK 5.7tDKK 1.8tDKK 216.6b13.5x26.4x3.2x
Sun, 03 Dec 2023DKK 5.4tDKK 1.8tDKK 216.7b13.7x25.1x3.1x
Tue, 31 Oct 2023DKK 5.2tDKK 1.9tDKK 302.1b12.5x17.3x2.8x
Thu, 28 Sep 2023DKK 5.2tDKK 1.9tDKK 285.4b13x18.4x2.8x
Sat, 26 Aug 2023DKK 5.3tDKK 1.9tDKK 283.3b12.9x18.9x2.8x
Mon, 24 Jul 2023DKK 5.1tDKK 1.9tDKK 319.5b13.4x16.1x2.7x
Wed, 21 Jun 2023DKK 5.1tDKK 1.9tDKK 322.3b13.7x15.8x2.6x
Fri, 19 May 2023DKK 5.3tDKK 1.9tDKK 324.3b14.6x16.2x2.7x
Sun, 16 Apr 2023DKK 5.1tDKK 1.9tDKK 342.1b15.1x14.9x2.7x
Price to Earnings Ratio

14.9x


Total Market Cap: DKK 5.1tTotal Earnings: DKK 342.1bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.4x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 15.9x which is lower than its 3-year average PE of 22.4x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 11% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market1.10%
Consumer Staples3.94%
Energy3.09%
Utilities2.05%
Telecom2.01%
Industrials1.70%
Real Estate1.17%
Healthcare0.81%
Materials0.44%
Financials0.011%
Tech-0.79%
Consumer Discretionary-1.43%
Sector PE
  • Investors favour the Utilities sector the most for future growth which is trading above its 3-year average PE ratio.
    • This is likely because analysts are expecting annual earnings growth of 23.0% and investors are willing to pay a premium for that growth.
  • The Consumer Discretionary sector is the least preferred by investors for future growth, which is trading below its 3-year average of 17.5x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 37% over the next 5 years.
  • This is better than its past earnings decline of 36% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 16% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVO B Novo NordiskDKK 240.101.4%
+DKK 14.2b		-40.6%PE10.4xHealthcare
DSV DSVDKK 1.62k3.1%
+DKK 11.5b		54.0%PE46xIndustrials
CARL B CarlsbergDKK 859.004.8%
+DKK 5.2b		6.4%PE19.1xConsumer Staples
ORSTED ØrstedDKK 161.502.1%
+DKK 4.3b		-36.6%PE123.5xUtilities
VWS Vestas Wind SystemsDKK 189.501.6%
+DKK 3.0b		128.6%PE32.1xIndustrials
See more

Market Insights

Header cover image
What’s happening with Renewables & EVs?
Richard Bowman avatar
Richard Bowman
Part 1 of 3 in our “What’s happening with…” series, where we look back on the investment themes that were all the rage just a few years ago and see how they're doing now.
Continue reading
How to spot the winners in 2026's IPOs

Latest News

VWS
DKK 189.50
Vestas Wind Systems
7D
1.6%
1Y
128.6%
GMAB
DKK 1,788.50
Genmab
7D
1.7%
1Y
53.1%
KBHL
DKK 6,300.00
Københavns Lufthavne
7D
-1.9%
1Y
-1.3%
AMBU B
DKK 65.70
Ambu
7D
-4.9%
1Y
-41.4%

AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside

Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.
MAERSK B
DKK 15,880.00
A.P. Møller - Mærsk
7D
-0.8%
1Y
73.6%

MAERSK B: Prolonged Freight Weakness And Muted Transport Cycle Will Pressure Earnings

Analysts have lifted the fair value estimate for A.P. Møller - Mærsk to DKK 13,349 from DKK 12,240, citing adjusted revenue growth assumptions, higher profit margin expectations, and a lower future P/E of about 31x that reflects the mix of recent target hikes and downgrades across the Street. Analyst Commentary Recent Street research on A.P. Møller-Mærsk reflects a split view, with some analysts lifting targets and ratings while others stay cautious or move to more conservative stances.
HLUN B
DKK 39.74
H. Lundbeck
7D
-2.6%
1Y
44.4%

HLUN B: Late-Stage Neurology Trials And Dividend Policy Will Support Margins

Analysts have adjusted their DKK price target on H. Lundbeck slightly, reflecting only minor tweaks to revenue growth, profit margin, and future P/E assumptions in their updated models.
DANSKE
DKK 317.50
Danske Bank
7D
-0.5%
1Y
65.1%

DANSKE: Future Returns Will Depend On Executing Buybacks And Dividend Plans

Danske Bank's analyst price target has moved higher, with the fair value estimate shifting from DKK 234.54 to DKK 317.17 as analysts factor in updated assumptions around slightly lower revenue growth, a small uplift in profit margin, and a higher future P/E multiple. Analyst Commentary Recent research on Danske Bank has generally featured higher price targets, but the tone is not uniformly upbeat.
NKT
DKK 907.50
NKT
7D
4.7%
1Y
106.1%

NKT: Elevated Expectations Will Face Growing Execution Risk On Major Projects

Analysts have lifted the fair value estimate for NKT to about DKK 522 per share from roughly DKK 435, citing updated assumptions for revenue growth, profit margins and future P/E levels, in light of recent price target changes including JPMorgan's move to DKK 752 and fresh downgrades from other houses. Analyst Commentary Recent research paints a mixed picture around NKT, with some high profile houses lifting price targets while several bearish analysts have turned more cautious.
NOVO B
DKK 240.10
Novo Nordisk
7D
1.4%
1Y
-40.6%

NOVO B: Future Returns Will Rely On Weekly Diabetes And Obesity Treatments

Narrative Update: Novo Nordisk Price Target Shift The analyst price target for Novo Nordisk has been adjusted slightly higher to DKK 309.77 from DKK 309.63. This reflects updated analyst assumptions that incorporate revised revenue growth, profit margin and future P/E inputs.
FLS
DKK 529.50
FLSmidth
7D
5.0%
1Y
103.5%
CARL B
DKK 859.00
Carlsberg
7D
4.8%
1Y
6.4%

CARL B: Non Alcoholic Shift And Britvic Integration Will Drive Rerating

Carlsberg's analyst price targets have been nudged higher, with several firms moving to more positive ratings and citing the pivot toward non alcoholic categories following the Britvic deal as a key driver for adjusting fair value assumptions around revenue growth, profit margins and future P/E expectations in DKK terms. Analyst Commentary Recent Street research on Carlsberg centers on how the Britvic acquisition reshapes the group toward non alcoholic categories and how that shift might influence valuation, execution risk and growth optionality in Europe.
PNDORA
DKK 471.40
Pandora
7D
-2.0%
1Y
-46.7%

PNDORA: Elevated EBIT Margin Expectations Will Sustain Cautious View On Earnings Multiple

Pandora's analyst price target remains at DKK 340, with analysts pointing to slightly adjusted assumptions around discount rate, revenue growth, profit margin and future P/E as justification for keeping the target unchanged. What's in the News Pandora's AGM held on 11 March 2026 approved an amendment to article 7.3 of the Articles of Association, following an earlier proposal ahead of the meeting (company AGM documentation).
DSV
DKK 1,624.50
DSV
7D
3.1%
1Y
54.0%

DSV: Schenker Synergies And 2026 Guidance Will Support Stronger Earnings Power

DSV's analyst price targets have edged higher, with recent upward revisions of up to DKK 414 as analysts adjust fair value assumptions slightly, including a marginally higher projected profit margin and P/E multiple. Analyst Commentary Recent research updates cluster around higher price targets for DSV, with several banks adjusting their fair value assumptions and published target ranges.
COLO B
DKK 434.90
Coloplast
7D
-1.8%
1Y
-35.1%

COLO B: New CEO Appointment And Reset P/E Will Support Future Re Rating

Coloplast's analyst fair value target has been trimmed from DKK 579.78 to DKK 567.16, as analysts factor in slightly lower long term growth, modestly softer margin assumptions and small adjustments to future P/E expectations following a mix of recent target cuts and one upgrade. Analyst Commentary Recent research on Coloplast has been mixed, with several target cuts alongside one upgrade.
DEMANT
DKK 191.80
Demant
7D
-1.9%
1Y
-10.2%

DEMANT: Recent Upgrades And 2026 Guidance May Support Further Upside

Analysts have trimmed the fair value estimate for Demant slightly to DKK 231.61 from DKK 232.17, reflecting a modest recalibration of price targets after a mix of recent upgrades and target reductions across the Street. Analyst Commentary Recent research on Demant has been mixed, with both upgrades and target cuts contributing to the slightly lower blended fair value estimate.
ORSTED
DKK 161.50
Ørsted
7D
2.1%
1Y
-36.6%